Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

DNA × Myeloid × Clear all

Status

Sponsor Class

Study Type

Observational 1

Sponsor

Cancer Type

Head & Neck 3 Thoracic 2 Other hematologic neoplasm 2 CNS 2 Tumor-Agnostic 1 Myeloid 1 Gynecologic 1 Gastrointestinal 1 Breast 1

Conditions

Leukemia, Myelogenous, Chronic, BCR-ABL Positive 1

Interventions

Cyclophosphamide 222 fludarabine phosphate 192 Azacitidine 160 fludarabine 155 Busulfan 143 Cytarabine 133 Imatinib Mesylate 131 Mycophenolic Acid 120 Whole-Body Irradiation 114 Tacrolimus 112 Peripheral Blood Stem Cell Transplantation 107 Melphalan 93 Cyclosporine 93 Antilymphocyte Serum 91 Filgrastim 87 Decitabine 84 Methotrexate 82 nilotinib 79 ruxolitinib 69 venetoclax 65 Dasatinib 58 Stem Cell Transplantation 55 Granulocyte Colony-Stimulating Factor 55 Radiotherapy 50 thymoglobulin 48 Thiotepa 48 Specimen Handling 42 Etoposide 42 Clofarabine 38 Cord Blood Stem Cell Transplantation 37

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT05605379 2024-08-14

CML Piramid

University Hospital, Bordeaux

MyeloidOther hematologic neoplasm

Leukemia, Myelogenous, Chronic, BCR-ABL Positive

Data powered by HemOnc (CC BY 4.0) Colophon ⚡